TLSA
$0.76
Tiziana Life Sciences
($.03)
(3.21%)
TLSA
Earnings Whisper ®
N/A
1st Quarter March 2023
Consensus:  $0.00
Revenue:  N/A
Wednesday
Apr 26
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when TLSA reports earnings?
Beat
Meet
Miss

Where is TLSA's stock price going from here?
Up
Flat
Down
Stock chart of TLSA
Analysts
Summary of analysts' recommendations for TLSA
Score
Grade
Pivots
Resistance
$0.89
$0.84
$0.80

$0.75

Support
$0.71
$0.66
$0.62
Tweet
Growth
Description
Tiziana Life Sciences PLC is a biotechnology company. It focuses on the clinical development for the treatment of cancers, chronic inflammatory and autoimmune neurodegenerative disorders. The company's product pipeline consists of Foralumab TZLS-401 and Milciclib TZLS-201 which are in clinical stage. Tiziana Life Sciences PLC is based in London, United Kingdom.
›